Article

Sonar findings of the uterus in patients on medroxyprogesterone acetate (Depo Provera) 150 mg injection

Published in: South African Family Practice
Volume 51 , issue 6 , 2009 , pages: 486–488

DOI: 10.1080/20786204.2009.10873910

Author(s): LA De Wilde Department of Family Medicine, Faculty of Health Sciences, , WJ Steinberg Department of Family Medicine, Faculty of Health Sciences, , M Nel Department of Biostatistics, Faculty of Health Sciences,

Keywords: sonar , ultrasound , uterus , endometrium , Depo Provera , medroxyprogesterone acetate , injection

Download full text Get new issue alerts

Abstract

Background: Depo Provera (medroxyprogesterone acetate) 150 mg intramuscular injection every 12 weeks is one of the most common, effective, affordable and popular methods of contraception. Depo Provera shows excellent results in comparison to oral contraceptive agents as well as the contraceptive patch.

« Family medicine, primary health care and HIV medicine—a ‘new’ clinical speciality and its role in the South African HIV pandemic

The prevalence of exercise-induced asthma among school children »